Related Experiment Videos
Effect of chronic right ventricular apical pacing on left ventricular function.
James H O'Keefe1, Hussam Abuissa, Philip G Jones
1Mid-America Heart Institute, Kansas City, Missouri 64111, USA. jhokeefe@cc-pc.com
The American Journal of Cardiology
|March 11, 2005
Summary
Beta-blocker therapy significantly improves left ventricular ejection fraction (LVEF) in patients with impaired heart function. Conversely, permanent pacemakers are linked to a decrease in LVEF.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Left ventricular ejection fraction (LVEF) changes in patients with baseline impaired function are not well understood.
- Assessing determinants of LVEF change is crucial for managing heart failure.
Purpose of the Study:
- To identify key factors influencing changes in left ventricular ejection fraction (LVEF) over time.
- To determine predictors for LVEF improvement and decline in patients with reduced baseline LVEF.
Main Methods:
- Retrospective analysis of a nuclear database including patients with baseline LVEF 25-40%.
- Inclusion criteria required a follow-up gated single-photon emission computed tomographic study approximately 18 months later.
- Patients were categorized into EF increase (> or =10 points) or EF decrease (> or =7 points) groups.
Main Results:
- Beta-blocker therapy was the strongest predictor of LVEF improvement (odds ratio 3.9, p=0.002).
- Permanent right ventricular apical pacemaker use was the strongest independent predictor of LVEF decrease (odds ratio 6.6, p=0.002).
- The EF increase group showed an average LVEF rise from 33% to 51%; the EF decrease group showed a drop from 35% to 25%.
Conclusions:
- Beta-blocker therapy is a major independent predictor for significant LVEF improvement.
- Permanent right ventricular apical pacing is the strongest predictor for significant LVEF decrease.
- These findings highlight distinct therapeutic and device-related influences on LVEF dynamics.